Publications by authors named "C F Takakura"

Common variable immunodeficiency (CVID) is one of the inborn errors of immunity that have the greatest clinical impact. Rates of morbidity and mortality are higher in patients with CVID who develop liver disease than in those who do not. The main liver disorder in CVID is nodular regenerative hyperplasia (NRH), the cause of which remains unclear and for which there is as yet no treatment.

View Article and Find Full Text PDF

Background: Innate immunity by natural killer (NK) cells, macrophages, and neutrophils cause severe rejections in xenotransplantation. Therefore, the development of strategies for suppressing macrophages has considerable potential in practical applications of xenotransplantation. Recently, we found that human CD31 on swine endothelial cells (SECs) suppresses neutrophil-mediated xenogeneic rejection through homophilic binding.

View Article and Find Full Text PDF

Although xenografts are one of the most attractive strategies for overcoming the shortage of organ donors, cellular rejection by macrophages is a substantial impediment to this procedure. It is well known that macrophages mediate robust immune responses in xenografts. Macrophages also express various inhibitory receptors that regulate their immunological function.

View Article and Find Full Text PDF
Article Synopsis
  • - The study explores how suppressing macrophage function, specifically through the T-cell immunoglobulin and ITIM domain (TIGIT), can potentially reduce xenogeneic rejection in organ transplants.
  • - Researchers co-cultured naïve porcine aortic endothelial cells (PAEC) and a transfectant with TIGIT, finding that TIGIT reduced the cytotoxicity of M1 macrophages and decreased the production of pro-inflammatory cytokines like TNFα and IL-1β.
  • - Overall, the study suggests that TIGIT may help protect against macrophage-induced cell damage during xenogeneic rejection, likely through mechanisms involving SHP-1 phosphorylation.
View Article and Find Full Text PDF

Background: Three drugs - pentavalent antimonials, amphotericin B and pentamidine - are currently used for leishmaniasis treatment. They are administered for long periods, only parenterally, and have high cardiac, renal and hepatic toxicities. Therefore, the investigation of new compounds is required.

View Article and Find Full Text PDF